{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895388567680.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1136/ard.59.4.243"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S000349672438238X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S000349672438238X?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1136/ard.59.4.243"}}],"dc:title":[{"@value":"Cytokines and systemic lupus erythematosus"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380866223601086721","@type":"Researcher","foaf:name":[{"@value":"Gillian S Dean"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866223601086722","@type":"Researcher","foaf:name":[{"@value":"Jonathan Tyrrell-Price"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866223601086723","@type":"Researcher","foaf:name":[{"@value":"Esther Crawley"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866223601086720","@type":"Researcher","foaf:name":[{"@value":"David A Isenberg"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00034967"}],"prism:publicationName":[{"@value":"Annals of the Rheumatic Diseases"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2000-04","prism:volume":"59","prism:number":"4","prism:startingPage":"243","prism:endingPage":"251"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S000349672438238X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S000349672438238X?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1136/ard.59.4.243"}],"createdAt":"2002-07-27","modifiedAt":"2025-01-06","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002214394547200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Modifying Effect of <i>N</i>‐Acetyltransferase 2 Genotype on the Association Between Systemic Lupus Erythematosus and Consumption of Alcohol and Caffeine‐Rich Beverages"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168770764672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280628246144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Distinct transcriptome architectures underlying lupus establishment and exacerbation"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1136/ard.59.4.243"},{"@type":"CROSSREF","@value":"10.1002/acr.22282_references_DOI_LW8j9Bwu6jYqTlpCqoToL3Qct2I"},{"@type":"CROSSREF","@value":"10.1177/09612033211042293_references_DOI_LW8j9Bwu6jYqTlpCqoToL3Qct2I"},{"@type":"CROSSREF","@value":"10.1016/j.cell.2022.07.021_references_DOI_LW8j9Bwu6jYqTlpCqoToL3Qct2I"}]}